Download the full agenda PDF Day 1 Main Conference June 4, 2026 Registration and Breakfast Wade AckermanPartnerCovington & Burling LLP Kalah AuchinclossPresidentCanal Row Advisors Sean GriffinPartnerSidley Austin LLP Scott BrunnerChief Executive OfficerAlliance for Pharmacy Compounding The GLP-1 boom has led to rapid re-evaluation by the federal and state governments
What is the recommended application cycle
Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding
Clinical trial data from the STEP 4 and STEP 5 studies showed that participants who continued semaglutide maintained meaningful weight loss over one to two years, even though the rate of loss flattened compared with the earliest weeks
Rather than interpreting these changes as side effects to escape, most patients find success by embracing new eating patterns: focusing on nutrient-dense whole foods, experimenting with different textures and temperatures, and scheduling meals proactively rather than eating in response to cravings
Transferrin-mediated cellular iron delivery